5 Stocks Raising The Health Care Sector Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 83 points (0.5%) at 16,304 as of Monday, Dec. 23, 2013, 11:55 AM ET. The NYSE advances/declines ratio sits at 2,307 issues advancing vs. 673 declining with 118 unchanged.

The Health Care sector currently sits up 1.1% versus the S&P 500, which is up 0.6%. Top gainers within the sector include United Therapeutics Corporation ( UTHR), up 24.1%, Illumina ( ILMN), up 2.3%, Actavis ( ACT), up 2.2%, Vertex Pharmaceuticals ( VRTX), up 2.0% and Humana ( HUM), up 1.7%.

TheStreet would like to highlight 5 stocks pushing the sector higher today:

5. Baxter International ( BAX) is one of the companies pushing the Health Care sector higher today. As of noon trading, Baxter International is up $0.54 (0.8%) to $68.92 on light volume. Thus far, 1.1 million shares of Baxter International exchanged hands as compared to its average daily volume of 3.9 million shares. The stock has ranged in price between $68.00-$68.94 after having opened the day at $68.55 as compared to the previous trading day's close of $68.39.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $36.4 billion and is part of the health services industry. The company has a P/E ratio of 17.0, below the S&P 500 P/E ratio of 17.7. Shares are up 2.6% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Gold Is Great Again Thanks to North Korea's Kim Jong-Un

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

These Stocks Are Ready to Reverse Course